MedTrace Logo

Social Media-based Active Self-report on Incidence and Outcomes of Adverse Events in NK/TCL Patients

NCT03079544 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 665

Last updated 2021-09-14

No results posted yet for this study

Summary

The purpose of this study is to collect data from patients by social media and self-report on the adverse events and outcomes happened with patients with extranodal natural killer/T-cell lymphoma, nasal type, who are treated outside of clinical trials in China.

Conditions

  • Extranodal NK-T-Cell Lymphoma, Nasal Type

Interventions

COMBINATION_PRODUCT

L-Asparaginase or or Pegaspargase containing chemotherapy

Patients receive at least one cycle of combinational chemotherapy containing L-asparaginas or Pegaspargase.

Sponsors & Collaborators

  • Rong Tao

    lead OTHER

Principal Investigators

  • Rong Tao, MD · Xinhua hospital, Shanghai Jiao Tong University of Medicine

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-03-08
Primary Completion
2021-08-30
Completion
2021-08-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03079544 on ClinicalTrials.gov